Respiratory Syncytial Virus Infection: Old Challenges and New Approaches.

Competing Interests: Potential conflicts of interest. OR has received research grants to institution from Janssen, Merck, NIH, and the Bill & Melinda Gates foundation; and fees for participation in Advisory Boards from Sanofi-Pasteur, Merck, Lilly, Adagios, and Pfizer and for lectures from Pfizer, Sanofi-Pasteur, and Astra-Zeneca. AM has received fees for participation in Advisory Boards from Janssen, Merck, and Sanofi-Pasteur, grants to institution from Merck and Janssen, and fees for lectures from Sanofi-Pasteur and Astra-Zeneca. RR-F has received fees for lectures from Abbvie, Astra Zeneca, and Sanofi; fees for participation in Advisory Boards from Sanofi, Astra Zeneca and Merck; and research grants from FIS (Fondo de Investigaciones Sanitarias). Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.